iSpecimen Inc.
ISPC
$2.55
-$0.08-3.04%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -87.25% | -79.24% | -67.73% | -43.77% | -13.05% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -87.25% | -79.24% | -67.73% | -43.77% | -13.05% |
| Cost of Revenue | -73.15% | -64.08% | -51.34% | -24.11% | 6.14% |
| Gross Profit | -109.83% | -99.40% | -85.50% | -63.36% | -32.56% |
| SG&A Expenses | -31.76% | -48.11% | -8.29% | -13.99% | -10.15% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -43.86% | -50.47% | -23.16% | -18.50% | -7.04% |
| Operating Income | 13.09% | 29.46% | -24.31% | -7.40% | 2.25% |
| Income Before Tax | 1.33% | 16.09% | -21.09% | 0.03% | 2.73% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 1.33% | 16.09% | -21.09% | 0.03% | 2.73% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.33% | 16.09% | -21.09% | 0.03% | 2.73% |
| EBIT | 13.09% | 29.46% | -24.31% | -7.40% | 2.25% |
| EBITDA | 12.85% | 30.09% | -24.89% | -7.16% | 2.86% |
| EPS Basic | 85.59% | 87.11% | 63.28% | 60.13% | 53.43% |
| Normalized Basic EPS | 85.59% | 87.11% | 63.28% | 60.13% | 53.43% |
| EPS Diluted | 85.59% | 87.11% | 63.28% | 60.13% | 53.43% |
| Normalized Diluted EPS | 85.59% | 87.11% | 63.28% | 60.13% | 53.43% |
| Average Basic Shares Outstanding | 530.39% | 545.99% | 444.92% | 244.40% | 160.04% |
| Average Diluted Shares Outstanding | 530.39% | 545.99% | 444.92% | 244.40% | 160.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |